Generation of CD3+ CD56+ cytokine-induced killer cells and their in vitro cytotoxicity against pediatric cancer cells.
about
Immunotherapeutic Intervention against Sarcomas.Combining antiangiogenic therapy with adoptive cell immunotherapy exerts better antitumor effects in non-small cell lung cancer modelsCIK cells from patients with HCC possess strong cytotoxicity to multidrug-resistant cell line Bel-7402/RCytokine-induced killer cells promote antitumor immunityImplication of combined PD-L1/PD-1 blockade with cytokine-induced killer cells as a synergistic immunotherapy for gastrointestinal cancer.Cholangiocarcinoma-derived exosomes inhibit the antitumor activity of cytokine-induced killer cells by down-regulating the secretion of tumor necrosis factor-α and perforin.Effect of anti-asthma Chinese medicine Chuankezhi on the anti-tumor activity of cytokine-induced killer cells.Clinical response of advanced cancer patients to cellular immunotherapy and intensity-modulated radiation therapy.Cytokine induced killer cells as promising immunotherapy for solid tumors.Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors.Targeting cancer stem cells for treatment of glioblastoma multiforme.A killer choice for cancer immunotherapy.Adoptive immunotherapy against sarcomas.Cytokine-induced killer cells as immunotherapy for solid tumors: current evidence and perspectives.Cancer Immunotherapy with Cytokine-Induced Killer Cells.Adoptive Cellular Therapy (ACT) for Cancer Treatment.Synergistic antitumor effect of combining metronomic chemotherapy with adoptive cell immunotherapy in nude mice.Efficient lysis of rhabdomyosarcoma cells by cytokine-induced killer cells: implications for adoptive immunotherapy after allogeneic stem cell transplantation.Clinical effects of autologous cytokine-induced killer cell-based immunotherapy in the treatment of endometrial cancer: a case report and literature reviewInnovative Clinical Perspectives for CIK Cells in Cancer Patients.Safety and activity of PD-1 blockade-activated DC-CIK cells in patients with advanced solid tumors.
P2860
Q34196481-1BE147A7-8E85-4689-8980-4E16CE2ECDC9Q34782683-F8C7376E-175E-4B80-B7BB-69624D86230AQ35045325-A2503DD5-77A0-41D2-8848-AA4FE79D97CDQ36741617-91CA3713-9CF1-4D42-8428-4878EF3894C6Q36962962-644503F5-CC4C-4260-8B60-B78AC3CECAC8Q37084575-0551141E-CE27-4144-AE68-3C0E77A046EAQ37353913-0E79584E-514E-48FC-BD48-D0C946921692Q37381085-6D41DD2A-165C-478F-AD20-E5A0970EE2CBQ37895924-D4C9DD09-AAD6-4896-9176-18F28A763CF7Q38002494-1DA4A20D-DBC9-4EEE-8114-ACC4D093D1E5Q38099729-DB433483-08F4-4A46-8C2C-700E53A868ABQ38208944-CA1EC064-B015-491B-A6EC-A33C27A27CD3Q38291193-30AD2FF3-06A3-4502-85F6-EB4662149345Q38574526-F5B40F0B-9E06-466C-8C0A-DCBE2D68D9AAQ38687547-1563ED61-433A-4BD5-A2C3-1DDD4C46330EQ38848219-06E52861-7C60-4EAE-8473-195D4EBCF05FQ39015610-A4AD7778-A8A3-4882-96BE-2F555AAB6054Q42123389-96E6D187-1F09-441B-8B73-E4971435BFC1Q42283208-3C7A7995-6AB2-4AE6-B198-6B9DEAAF65CCQ49693858-DD099463-6BE9-46F3-B2B8-6DC5770E40ECQ52597541-3F447C34-A639-4D9E-8866-302BCCABEC28
P2860
Generation of CD3+ CD56+ cytokine-induced killer cells and their in vitro cytotoxicity against pediatric cancer cells.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Generation of CD3+ CD56+ cytok ...... gainst pediatric cancer cells.
@en
type
label
Generation of CD3+ CD56+ cytok ...... gainst pediatric cancer cells.
@en
prefLabel
Generation of CD3+ CD56+ cytok ...... gainst pediatric cancer cells.
@en
P2093
P356
P1476
Generation of CD3+ CD56+ cytok ...... gainst pediatric cancer cells.
@en
P2093
Busaba Rerkamnuaychoke
Saengsuree Jootar
Samart Pakakasama
Sawang Petvises
Suradej Hongeng
Surapon Worapongpaiboon
P2888
P304
P356
10.1007/BF02983217
P577
2003-02-01T00:00:00Z